Vertex Pharmaceuticals VRTX
Last Price
52 Week Range
$362.50 - $519.68
Next Earnings Date
Feb 09 2026 (Estimate)
Next Earnings Date
Feb 09 2026 (Est.)
Last Price
VRTX Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Vertex Pharmaceuticals Incorporated | 10-Q | November 4, 2025 | |
Vertex Pharmaceuticals Incorporated | 8-K | November 3, 2025 | |
Vertex Pharmaceuticals Incorporated | 10-Q | August 5, 2025 | |
Vertex Pharmaceuticals Incorporated | 8-K | August 4, 2025 | |
Vertex Pharmaceuticals Incorporated | 8-K | May 19, 2025 | |
Vertex Pharmaceuticals Incorporated | 8-K | May 14, 2025 | |
Vertex Pharmaceuticals Incorporated | 10-Q | May 6, 2025 | |
Vertex Pharmaceuticals Incorporated | 8-K | May 5, 2025 | |
Vertex Pharmaceuticals Incorporated | ARS | April 3, 2025 | |
Vertex Pharmaceuticals Incorporated | DEF 14A | April 3, 2025 | |
Vertex Pharmaceuticals Incorporated | DEFA14A | April 3, 2025 | |
Vertex Pharmaceuticals Incorporated | 8-K | March 28, 2025 | |
Vertex Pharmaceuticals Incorporated | 10-K | February 13, 2025 | |
Vertex Pharmaceuticals Incorporated | S3ASR | February 13, 2025 | |
Vertex Pharmaceuticals Incorporated | 8-K | February 10, 2025 | |
Vertex Pharmaceuticals Incorporated | 8-K | December 20, 2024 | |
Vertex Pharmaceuticals Incorporated | 10-Q | November 5, 2024 | |
Vertex Pharmaceuticals Incorporated | 8-K | November 4, 2024 | |
Vertex Pharmaceuticals Incorporated | 8-K | August 16, 2024 | |
Vertex Pharmaceuticals Incorporated | 10-Q | August 2, 2024 | |
Vertex Pharmaceuticals Incorporated | 8-K | August 1, 2024 | |
Vertex Pharmaceuticals Incorporated | 8-K | June 27, 2024 | |
Vertex Pharmaceuticals Incorporated | 8-K | May 20, 2024 | |
Vertex Pharmaceuticals Incorporated | 8-K | May 15, 2024 | |
Vertex Pharmaceuticals Incorporated | 10-Q | May 7, 2024 | |
Vertex Pharmaceuticals Incorporated | 8-K | May 6, 2024 | |
Vertex Pharmaceuticals Incorporated | PX14A6G | April 16, 2024 | |
Vertex Pharmaceuticals Incorporated | 8-K | April 11, 2024 | |
Vertex Pharmaceuticals Incorporated | DEFA14A | April 4, 2024 | |
Vertex Pharmaceuticals Incorporated | ARS | April 4, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.